The pill is here – US launch for Novo Nordisk

The client’s challenge

How do you make a pharmaceutical launch light up a city? In conjunction with the JPM Healthcare Conference, which draws industry leaders, investors and media to San Francisco, Novo Nordisk was about to launch oral Wegovy: the world’s first GLP-1 pill for weight loss. The challenge was twofold: make a historic product launch cut through the noise of the conference and close the distance between the Novo Nordisk brand and its product brands, enabling them to move fast – and as one.

The &Robin approach

We designed a bold, city-wide brand activation built around a single unexpected tactic: glow cars. Novo Nordisk-branded vehicles, which captured attention throughout downtown San Francisco traffic, were paired with high-visibility airport moments also featuring the pill. The activation turned the city itself into a moving consumer brand platform during a week where every healthcare decision-maker was watching.

Outcome

During the most watched week in healthcare, Novo Nordisk had a presence that was hard to miss and easy to remember – on the streets, at the airport and in the feeds of decision makers. The activation demonstrated what happens when brand and business move together: coherence, momentum and cut-through that no paid media alone can manufacture.